Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Global testing of shifts in metabolic phenotype.

Fazelzadeh P, Hoefsloot HCJ, Hankemeier T, Most J, Kersten S, Blaak EE, Boekschoten M, van Duynhoven J.

Metabolomics. 2018 Oct 4;14(10):139. doi: 10.1007/s11306-018-1435-8.

2.

Effects of Grape Pomace Polyphenolic Extract (Taurisolo®) in Reducing TMAO Serum Levels in Humans: Preliminary Results from a Randomized, Placebo-Controlled, Cross-Over Study.

Annunziata G, Maisto M, Schisano C, Ciampaglia R, Narciso V, Tenore GC, Novellino E.

Nutrients. 2019 Jan 10;11(1). pii: E139. doi: 10.3390/nu11010139.

3.

Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial.

Bo S, Gambino R, Ponzo V, Cioffi I, Goitre I, Evangelista A, Ciccone G, Cassader M, Procopio M.

Nutr Diabetes. 2018 Sep 20;8(1):51. doi: 10.1038/s41387-018-0059-4.

4.

Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study.

Hussain SA, Marouf BH, Ali ZS, Ahmmad RS.

Clin Interv Aging. 2018 Sep 5;13:1621-1630. doi: 10.2147/CIA.S172758. eCollection 2018.

5.

Comparison of bone turnover markers in peripheral blood and bone marrow aspirate.

Ornstrup MJ, Kjær TN, Harsløf T, Jørgensen NR, Pedersen SB, Langdahl BL.

Bone. 2018 Nov;116:315-320. doi: 10.1016/j.bone.2018.08.023. Epub 2018 Aug 31.

PMID:
30176391
6.

Gene Expression of Sirtuin-1 and Endogenous Secretory Receptor for Advanced Glycation End Products in Healthy and Slightly Overweight Subjects after Caloric Restriction and Resveratrol Administration.

Roggerio A, Strunz CMC, Pacanaro AP, Leal DP, Takada JY, Avakian SD, Mansur AP.

Nutrients. 2018 Jul 21;10(7). pii: E937. doi: 10.3390/nu10070937.

7.

Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial.

Sattarinezhad A, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M.

Diabetes Metab. 2019 Jan;45(1):53-59. doi: 10.1016/j.diabet.2018.05.010. Epub 2018 Jun 8.

PMID:
29983230
8.

The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk.

Mazza A, Schiavon L, Rigatelli G, Torin G, Montanaro F, Lenti S.

Food Funct. 2018 Jul 17;9(7):3845-3852. doi: 10.1039/c8fo00415c.

PMID:
29951651
9.

Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia.

Haghpanah S, Zarei T, Eshghi P, Zekavat O, Bordbar M, Hoormand M, Karimi M.

Ann Hematol. 2018 Oct;97(10):1919-1924. doi: 10.1007/s00277-018-3392-8. Epub 2018 Jun 21.

PMID:
29926158
10.

Resveratrol supplementation decreases blood glucose without changing the circulating CD14+CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

Khodabandehloo H, Seyyedebrahimi S, Esfahani EN, Razi F, Meshkani R.

Nutr Res. 2018 Jun;54:40-51. doi: 10.1016/j.nutres.2018.03.015. Epub 2018 Apr 6.

PMID:
29914666
11.

No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.

Poulsen MK, Nellemann B, Bibby BM, Stødkilde-Jørgensen H, Pedersen SB, Grønbaek H, Nielsen S.

Diabetes Obes Metab. 2018 Oct;20(10):2504-2509. doi: 10.1111/dom.13409. Epub 2018 Jul 5.

PMID:
29885082
12.

Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes.

de Ligt M, Bruls YMH, Hansen J, Habets MF, Havekes B, Nascimento EBM, Moonen-Kornips E, Schaart G, Schrauwen-Hinderling VB, van Marken Lichtenbelt W, Schrauwen P.

Mol Metab. 2018 Jun;12:39-47. doi: 10.1016/j.molmet.2018.04.004. Epub 2018 Apr 18.

13.

Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study.

Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH.

Clin Rheumatol. 2018 Aug;37(8):2035-2042. doi: 10.1007/s10067-018-4080-8. Epub 2018 Apr 3.

PMID:
29611086
14.

Two-Year Clinical Outcomes of the CONSEQUENT Trial: Can Femoropopliteal Lesions be Treated with Sustainable Clinical Results that are Economically Sound?

Albrecht T, Waliszewski M, Roca C, Redlich U, Tautenhahn J, Pech M, Halloul Z, Gögebakan Ö, Meyer DR, Gemeinhardt I, Zeller T, Müller-Hülsbeck S, Ott I, Tepe G.

Cardiovasc Intervent Radiol. 2018 Jul;41(7):1008-1014. doi: 10.1007/s00270-018-1940-1. Epub 2018 Mar 27.

PMID:
29589098
15.

Effects of 90 Days of Resveratrol Supplementation on Cognitive Function in Elders: A Pilot Study.

Anton SD, Ebner N, Dzierzewski JM, Zlatar ZZ, Gurka MJ, Dotson VM, Kirton J, Mankowski RT, Marsiske M, Manini TM.

J Altern Complement Med. 2018 Jul;24(7):725-732. doi: 10.1089/acm.2017.0398. Epub 2018 Mar 27.

16.

Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults - A randomized controlled trial.

Huhn S, Beyer F, Zhang R, Lampe L, Grothe J, Kratzsch J, Willenberg A, Breitfeld J, Kovacs P, Stumvoll M, Trampel R, Bazin PL, Villringer A, Witte AV.

Neuroimage. 2018 Jul 1;174:177-190. doi: 10.1016/j.neuroimage.2018.03.023. Epub 2018 Mar 13.

PMID:
29548848
17.

Supplementation with Resveratrol and Curcumin Does Not Affect the Inflammatory Response to a High-Fat Meal in Older Adults with Abdominal Obesity: A Randomized, Placebo-Controlled Crossover Trial.

Vors C, Couillard C, Paradis ME, Gigleux I, Marin J, Vohl MC, Couture P, Lamarche B.

J Nutr. 2018 Mar 1;148(3):379-388. doi: 10.1093/jn/nxx072.

PMID:
29546309
18.

Preliminary Clinical Effect Evaluation of Resveratrol in Adults with Allergic Rhinitis.

Lv C, Zhang Y, Shen L.

Int Arch Allergy Immunol. 2018;175(4):231-236. doi: 10.1159/000486959. Epub 2018 Mar 14.

PMID:
29539616
19.

The Oral Bioavailability of Trans-Resveratrol from a Grapevine-Shoot Extract in Healthy Humans is Significantly Increased by Micellar Solubilization.

Calvo-Castro LA, Schiborr C, David F, Ehrt H, Voggel J, Sus N, Behnam D, Bosy-Westphal A, Frank J.

Mol Nutr Food Res. 2018 May;62(9):e1701057. doi: 10.1002/mnfr.201701057. Epub 2018 Apr 30.

PMID:
29534330
20.

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

Malaguarnera G, Pennisi M, Bertino G, Motta M, Borzì AM, Vicari E, Bella R, Drago F, Malaguarnera M.

Nutrients. 2018 Mar 9;10(3). pii: E329. doi: 10.3390/nu10030329.

Supplemental Content

Loading ...
Support Center